ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences

PLEASANTON, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), today announced that their precision sleep apnea devices will be prominently featured in the scientific programs at upcoming medical conferences. The new scientific abstracts and podium presentations feature new data and additional data reporting on the efficacy, effectiveness, and safety of ProSomnus devices. The positive data adds to the expanding volume of independent evidence establishing precision oral devices as a leading treatment option for obstructive sleep apnea.

Read more at globenewswire.com